477202-00-9 Usage
Description
Ipilimumab is a CTLA-4 blocking antibody that was approved by the
U.S. FDA in March 2011 for the treatment of unresectable or metastatic
melanoma. Therefore, ipilimumab has an indirect effect on tumors that is
mediated through blockade of CTLA-4 negative signaling and
augmentation of T-cell activity. It is one of a handful of
immunostimulatory drugs (e.g., aldesleukin and interferon alfa-2b) now approved for cancer therapy.
Uses
Treatment of
oncology disease and HIV infection.
Brand name
Yervoy
Clinical Use
Antineoplastic agent:
Treatment of advanced (unresectable or metastatic)
melanoma in adults who have received prior therapy
Metabolism
Most likely removed by opsonisation via the
reticuloendothelial system when bound to T lymphocytes,
or by human antimurine antibody production.
Check Digit Verification of cas no
The CAS Registry Mumber 477202-00-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,7,2,0 and 2 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 477202-00:
(8*4)+(7*7)+(6*7)+(5*2)+(4*0)+(3*2)+(2*0)+(1*0)=139
139 % 10 = 9
So 477202-00-9 is a valid CAS Registry Number.